Company intelligence
Omivera
Measuring drug selectivity where it truly matters.
Biotechnology Research
Leiden, NL
4 employees
1 public signals
About Omivera
Welcome to Omivera! We are a chemical proteomics company based in Leiden, dedicated to helping scientists overcome one of the biggest challenges in kinase inhibitor development: the lack of physiologically relevant selectivity data. With our CellEKT platform, we can help you better understand the drug responses of your kinase inhibitor in your cellular models. We provide accurate, biologically relevant selectivity profiles starting from lead optimization and throughout the drug-development process. Our goal is to reduce clinical attrition rates and accelerate the development of safer, more effective kinase inhibitors.
Verified activity
Signals from Omivera
1 published signal